These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2731465)

  • 41. [Use of the insulin pump in diabetic children].
    Levy-Marchal C
    Soins Gynecol Obstet Pueric Pediatr; 1986 Mar; (58):9-12. PubMed ID: 3635985
    [No Abstract]   [Full Text] [Related]  

  • 42. The benefits of insulin pump therapy in children and adolescents with type 1 diabetes.
    Woerner S
    J Pediatr Nurs; 2014; 29(6):712-3. PubMed ID: 25176031
    [No Abstract]   [Full Text] [Related]  

  • 43. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of the pregnant diabetic by means of a portable insulin pump].
    Kölblová V; Dvoráková L; Hájková E; Krausová H
    Cesk Gynekol; 1986 Nov; 51(9):742-4. PubMed ID: 3791439
    [No Abstract]   [Full Text] [Related]  

  • 45. Mismanagement of infusion pumps.
    Sonnenberg GE; Chantelau E; Berger M
    Diabetes Care; 1982; 5(2):145. PubMed ID: 6927726
    [No Abstract]   [Full Text] [Related]  

  • 46. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study.
    Berhe T; Postellon D; Wilson B; Stone R
    Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of the biostator for programming the insulin infusion pump Microjet-Bolus-2 in the treatment of insulin-dependent diabetes mellitus].
    Sieradzki J; Szurkowska M
    Pol Arch Med Wewn; 1988 May; 79(5):271-7. PubMed ID: 3078197
    [No Abstract]   [Full Text] [Related]  

  • 48. Over-delivery of insulin by insulin pumps.
    Prendergast JJ; Dorsey C; Elsea V
    Diabetes Care; 1995 Aug; 18(8):1201-2. PubMed ID: 7587864
    [No Abstract]   [Full Text] [Related]  

  • 49. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Insulin portable pump vs. intensified conventional injections in diabetes].
    Gutman RA; Litwak LE; Fagin JA; Plantalech L; Steiner S
    Medicina (B Aires); 1985; 45(3):225-30. PubMed ID: 3915900
    [No Abstract]   [Full Text] [Related]  

  • 51. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates.
    van Bon AC; Dragt D; DeVries JH
    Diabetes Technol Ther; 2012 May; 14(5):447-8. PubMed ID: 22548715
    [No Abstract]   [Full Text] [Related]  

  • 53. Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.
    Tamborlane WV; Sikes KA; Steffen AT; Weinzimer SA
    Diabetes Res Clin Pract; 2006 Dec; 74 Suppl 2():S112-5. PubMed ID: 17182301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin Oil Staining to Avoid Infusion Set Cannula Crimping: A Personal Observation.
    Bossi AC
    J Diabetes Sci Technol; 2016 Sep; 10(5):1201-2. PubMed ID: 26902792
    [No Abstract]   [Full Text] [Related]  

  • 55. Glycemic control and treatment satisfaction in Saudi diabetic children on insulin pump therapy.
    Bin-Abbas BS; Sakati NA; Al-Ashwal AA
    Ann Saudi Med; 2006; 26(3):247-8. PubMed ID: 16861872
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical review: insulin pump-associated adverse events in adults and children.
    Ross PL; Milburn J; Reith DM; Wiltshire E; Wheeler BJ
    Acta Diabetol; 2015 Dec; 52(6):1017-24. PubMed ID: 26092321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients.
    Mecklenburg RS; Guinn TS; Sannar CA; Blumenstein BA
    Diabetes Care; 1986; 9(4):351-5. PubMed ID: 3743310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharma-clinics. How I treat... a type 1 diabetic patient with a portable insulin pump].
    Philips JC; Scheen A
    Rev Med Liege; 1996 Nov; 51(11):678-80. PubMed ID: 9011918
    [No Abstract]   [Full Text] [Related]  

  • 59. Sensor-augmented insulin-pump therapy in type 1 diabetes.
    Kerr D
    N Engl J Med; 2010 Nov; 363(21):2070-1; author reply 2071. PubMed ID: 21083395
    [No Abstract]   [Full Text] [Related]  

  • 60. Novo's research and development commitment to diabetes care.
    Kühl C
    Postgrad Med J; 1988; 64 Suppl 3():1-3. PubMed ID: 3074292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.